July/August 2024

NEWS & COLUMNS

6-7 NEWS
Roche and Ascidian in $1.8bn deal; Eli Lilly's Alzheimer's drug granted FDA approval

8-9 NEWS
Researchers identify major cause of IBD; EMA launches clinical trials advice pilots

10-11 DERMATOLOGY NEWS
UCB's Bimzelx approved by MHRA; Novartis' results for chronic spontaneous urticaria

12 DARWIN'S MEDICINE
Bayer's octopus move

14 START SMART
Collecting the right data in the right way for the right reasons

15 INNOVATIVE IMPACT BLOG
Making space to amplify impact

FEATURES

16-18 WOMEN IN PHARMA
Doina Ionescu, Merck's managing director for the UK and Ireland, talks about the progress that has been made in the pharma industry in the pursuit of equality and her passion for encouraging young girls to study STEM at school

20-21 UNLOCKING ACCESS TO CAR-T IN EUROPE: PROGRESS AND GROWING PAINS
CAR-Ts pose a unique challenge for healthcare systems, exacerbated by uncertainty around their long-term, real-world value

22-23 CREATIVITY AT CANNES LIONS 2024
Across almost every sector, brands are multiplying their investment in creativity. The results, showcased at festivals like Cannes, show the investment is paying off – solving business problems and establishing creativity as a genuine growth driver

16. Doina Ionescu, Merck’s managing director for the UK and Ireland